Delivery Order SPE2DB20D2104-SPE2DB25FNBCV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,021.03 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injections on August 25, 2025, with completion targeted for August 26, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a $10,016.78 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections. This firm fixed price contract, with an ultimate completion date of September 8, 2025, represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,178.52 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pen injections on June 24, 2025, with completion targeted for June 25, 2025. This competitively awarded, firm fixed-price delivery order represents fulfillment under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $13,146.50 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injections on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order was awarded without set-aside designation through open competition, reflecting the vendor's demonstrated capability to meet federal pharmaceutical procurement requirements. The contract is performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,812.94 to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen injections on August 29, 2025, with a completion date of September 2, 2025. This firm fixed-price, non-set-aside delivery order represents a pharmaceutical supply transaction supporting federal medical procurement needs. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, underscoring the company's role as...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of Zepbound 2.5 mg/0.5 ml pen injections. This competitively awarded, non-set-aside contract has a ceiling value of $10,683.61 with a firm fixed price structure and is scheduled for completion by May 5, 2025. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,083.86 to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen injections on September 24, 2025. This contract utilizes firm fixed pricing and was competitively awarded without any set-aside designation. The award was fulfilled by AmerisourceBergen's Corporate Office division, with performance at the company's headquarters in Conshohocken, Pennsylvania. The delivery order is scheduled for completion by September 25,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections at a firm fixed price of $37,100.84, with completion required by August 1, 2025. This competitive award carries no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA. The order will be fulfilled from the company's corporate office location...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,161.71 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injections on March 11, 2025, with completion scheduled for March 12, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $12,539.80 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on July 31, 2025. This firm fixed-price, competitively awarded delivery order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, with an ultimate completion date of August 1, 2025. The contract carries no set-aside designation and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNBCVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,062.90 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injections on September 22, 2025, with an ultimate completion date of September 23, 2025. This award was made under firm fixed-price terms with no set-aside designation, indicating competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a discrete purchase under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies a wide range of medications and medical commodities to military and veteran healthcare systems. The Zepbound order fulfills Defense Health Agency pharmaceutical requirements and exemplifies the type of specialty medication deliveries that characterize the company's extensive federal contract portfolio with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/22/25 |